课题基金 / 基金详情

ARE P27 AND P21 TUMOR SUPPRESSORS

ARE P27 AND P21 TUMOR SUPPRESSORS
P27 和 P21 是肿瘤抑制剂
批准号:
6173203
负责人:
Matthew L Fero
金额:
$8.78万
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-09-01 至 2001-08-31

项目摘要

项目成果

Matthew L Fero的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Applicant's Description): P27 and p21 are two recently discovered proteins which cause a G1 block to cell cycle progression in response to antimitogenic stimuli. Elimination of cell cycle checkpoints mediated by molecules such as these may contribute to cellular transformation or tumor progression. Dr. Fero, an oncologist who completed his medical training at the University of Washington and the Fred Hutchinson Cancer Research Center, has created transgenic mice in order to test these hypotheses. These mice will be studied to assess the overall phenotypic effect of p27 and p21 disruption alone and in combination. The susceptibility of these mice to the development of mammary and skin tumors, both spontaneously and following exposure to carcinogens, will then be determined. The project involves collaboration of scientists from the Basic Sciences and Public Health divisions of the Hutchinson Center with scientists at the Hematology and Biochemistry divisions of the University of Washington. Dr. Fero will enhance his basic science background further by combining molecular genetics and biostatistics coursework to his research program. His goals are to develop transgenic animal models which help to unravel the mysteries of cell cycle regulation and will contribute to the development of new classes of cancer therapeutic agents.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Cell Autonomy and Tumor Suppression by CDK inhibitors
Cell Autonomy and Tumor Suppression by CDK inhibitors
Cell Autonomy and Tumor Suppression by CDK inhibitors
Cell Autonomy and Tumor Suppression by CDK inhibitors
海外基金